ICU Medical Inc (ICUI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
ICU Medical Inc stock (ICUI) is currently trading at $129.40. ICU Medical Inc PE ratio is 4178.67. ICU Medical Inc PS ratio (Price-to-Sales) is 1.39. Analyst consensus price target for ICUI is $182.67. WallStSmart rates ICUI as Underperform.
- ICUI PE ratio analysis and historical PE chart
- ICUI PS ratio (Price-to-Sales) history and trend
- ICUI intrinsic value — DCF, Graham Number, EPV models
- ICUI stock price prediction 2025 2026 2027 2028 2029 2030
- ICUI fair value vs current price
- ICUI insider transactions and insider buying
- Is ICUI undervalued or overvalued?
- ICU Medical Inc financial analysis — revenue, earnings, cash flow
- ICUI Piotroski F-Score and Altman Z-Score
- ICUI analyst price target and Smart Rating
ICU Medical Inc
📊 No data available
Try selecting a different time range
ICUI Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · ICU Medical Inc (ICUI)
ICUI trades 73765% above its Graham fair value of $0.20, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
ICU Medical Inc (ICUI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
ICU Medical Inc (ICUI) Key Strengths (5)
Growing significantly faster than its price suggests
116.24% of shares held by major funds and institutions
Paying $1.39 for every $1 of annual revenue
Trading at 1.46x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
ICU Medical Inc (ICUI) Areas to Watch (5)
Revenue declining -14.10%, a shrinking business
Earnings declining -23.80%, profits shrinking
Very low returns on shareholder equity
Near-zero operating margins, business under pressure
Very thin margins, barely profitable
Supporting Valuation Data
ICU Medical Inc (ICUI) Detailed Analysis Report
Overall Assessment
This company scores 47/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.6/10) while 5 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Institutional Own., Price/Sales. Valuation metrics including PEG Ratio (0.07), Price/Sales (1.39), Price/Book (1.46) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Return on Equity. Growth concerns include Revenue Growth at -14.10%, EPS Growth at -23.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 0.04%, Operating Margin at 4.82%, Profit Margin at 0.03%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 0.04% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -14.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ICUI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ICUI's Price-to-Sales ratio of 1.39x trades at a deep discount to its historical average of 5x (0th percentile). The current valuation is 86% below its historical high of 9.91x set in Feb 2017, and 0% above its historical low of 1.39x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.7x as trailing revenue scaled faster than the stock price.
Compare ICUI with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for ICU Medical Inc (ICUI) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
ICU Medical Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2.2B with 14% decline year-over-year. Profit margins are thin at 3.0%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 36M in free cash flow and 61M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 14% YoY. Worth determining whether this is cyclical or structural.
ROE of 4.0% suggests the company isn't efficiently converting equity into profits.
What to Watch Next
Margin expansion: can ICU Medical Inc push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 4178.7x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact ICU Medical Inc.
Bottom Line
ICU Medical Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About ICU Medical Inc(ICUI)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.